Please provide your email address to receive an email when new articles are posted on . In patients with subclinical atrial fibrillation, apixaban lowered risk for stroke and systemic embolism vs.
Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at ...
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic ...
Blood thinner apixaban found to prevent strokes in patients with device-detected atrial fibrillation
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic ...
Please provide your email address to receive an email when new articles are posted on . Apixaban did not reduce recurrent stroke risk in patients with atrial cardiopathy without AF. The ARCADIA trial ...
Switching from Eliquis (apixaban) to rivaroxaban in Non-Valvular Atrial Fibrillation (NVAF) patients was associated with a higher risk of stroke/systemic embolism (S/SE) and major bleeding (MB) than ...
For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...
Most Medicare plans cover Eliquis (apixaban), which doctors may use to treat atrial fibrillation (AFib) and to help treat and prevent some types of blood clots. The Medicare Part D drug plan you ...
DEAR DR. ROACH: My husband is taking Eliquis for atrial fibrillation (AFib). The cost is going up, and there is no generic brand for Eliquis. Looking at drug websites, I have found other drugs that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results